HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HIMS - US4330001060 - Common Stock
36.31 USD
-1.2 (-3.2%)
36.26 USD
-0.05 (-0.14%)
Overall HIMS gets a fundamental rating of 5 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. HIMS has an average financial health and profitability rating. HIMS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year HIMS was profitable.
In the past year HIMS had a positive cash flow from operations.
In the past 5 years HIMS reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.99%, HIMS belongs to the top of the industry, outperforming 83.17% of the companies in the same industry.
The Return On Equity of HIMS (23.03%) is better than 91.09% of its industry peers.
The Return On Invested Capital of HIMS (5.84%) is better than 61.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
HIMS has a Profit Margin of 6.05%. This is amongst the best in the industry. HIMS outperforms 81.19% of its industry peers.
With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 64.36% of the companies in the same industry.
Looking at the Gross Margin, with a value of 75.01%, HIMS belongs to the top of the industry, outperforming 89.11% of the companies in the same industry.
HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HIMS is destroying value.
HIMS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HIMS has been increased compared to 5 years ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 4.41 indicates that HIMS is not in any danger for bankruptcy at the moment.
HIMS's Altman-Z score of 4.41 is amongst the best of the industry. HIMS outperforms 80.20% of its industry peers.
The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
HIMS's Debt to FCF ratio of 8.13 is in line compared to the rest of the industry. HIMS outperforms 53.47% of its industry peers.
HIMS has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.67, HIMS is not doing good in the industry: 70.30% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 4.41 |
ROIC/WACC0.67
WACC8.73%
2.3 Liquidity
A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
HIMS has a better Current ratio (1.88) than 76.24% of its industry peers.
HIMS has a Quick Ratio of 1.64. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a better Quick ratio (1.64) than 66.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.73% over the past year.
HIMS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 60.35% yearly.
Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 78.02%.
HIMS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.77% yearly.
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
3.2 Future
Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 41.75% on average per year.
The Revenue is expected to grow by 21.08% on average over the next years. This is a very strong growth
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y21.08%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 67.24, which means the current valuation is very expensive for HIMS.
HIMS's Price/Earnings is on the same level as the industry average.
HIMS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.15.
The Price/Forward Earnings ratio is 44.82, which means the current valuation is very expensive for HIMS.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
The average S&P500 Price/Forward Earnings ratio is at 36.22. HIMS is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 67.24 | ||
| Fwd PE | 44.82 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.18 | ||
| EV/EBITDA | 49.33 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
HIMS has a very decent profitability rating, which may justify a higher PE ratio.
HIMS's earnings are expected to grow with 23.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.66
PEG (5Y)1.11
EPS Next 2Y22.49%
EPS Next 3Y23.43%
5. Dividend
5.1 Amount
No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
36.31
-1.2 (-3.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners88.61%
Inst Owner Change15.84%
Ins Owners10.28%
Ins Owner Change-1.82%
Market Cap8.27B
Revenue(TTM)2.21B
Net Income(TTM)133.79M
Analysts67.62
Price Target49.13 (35.31%)
Short Float %32.97%
Short Ratio2.5
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-1.34%
PT rev (3m)-4.37%
EPS NQ rev (1m)-45.88%
EPS NQ rev (3m)-47.66%
EPS NY rev (1m)0.13%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 67.24 | ||
| Fwd PE | 44.82 | ||
| P/S | 3.74 | ||
| P/FCF | 69.18 | ||
| P/OCF | 25.43 | ||
| P/B | 14.23 | ||
| P/tB | 65.18 | ||
| EV/EBITDA | 49.33 |
EPS(TTM)0.54
EY1.49%
EPS(NY)0.81
Fwd EY2.23%
FCF(TTM)0.52
FCFY1.45%
OCF(TTM)1.43
OCFY3.93%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)5.66
PEG (5Y)1.11
Graham Number5.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 4.41 |
F-Score3
WACC8.73%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.73%
EPS 3YN/A
EPS 5Y60.35%
EPS Q2Q%-81.25%
EPS Next Y11.88%
EPS Next 2Y22.49%
EPS Next 3Y23.43%
EPS Next 5Y41.75%
Revenue 1Y (TTM)78.02%
Revenue growth 3Y75.77%
Revenue growth 5YN/A
Sales Q2Q%49.16%
Revenue Next Year59.73%
Revenue Next 2Y38.12%
Revenue Next 3Y31.11%
Revenue Next 5Y21.08%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year358.46%
EBIT Next 3Y94.49%
EBIT Next 5Y58.35%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HIMS.
What is the valuation status for HIMS stock?
ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HIMS & HERS HEALTH INC?
The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 11.88% in the next year.